What Medications Should You Avoid with MELAS Syndrome?
At a Glance
If you have MELAS syndrome, you must strictly avoid Valproic Acid (Depakote), Phenytoin, and Lactated Ringer's IV fluid. These treatments are toxic to your mitochondria and can trigger severe liver failure or dangerous lactic acidosis. Always carry an emergency medical alert card.
In this answer
3 sections
Yes, if you have MELAS syndrome, there are specific common medications and intravenous (IV) fluids that you must completely avoid. The most critical ones to avoid are Valproic Acid (Depakote), Phenytoin, and Lactated Ringer’s IV solution [1][2]. These treatments are dangerous because they directly inhibit your mitochondria—the “power plants” of your cells—or drastically worsen lactic acidosis, making them highly toxic to your body [1][3].
The Three Most Dangerous Treatments
It is crucial to ensure that any healthcare provider treating you, especially in an emergency setting, knows you cannot receive the following:
- Valproic Acid (Depakote): Often prescribed to treat seizures or migraines, this medication is strongly contraindicated (meaning it should never be used) in people with mitochondrial diseases like MELAS [1]. It blocks the mitochondria from doing their job and depletes carnitine, a nutrient your cells need for energy [1]. Taking this can trigger severe or even fatal liver failure and cause a metabolic crisis [1].
- Phenytoin: This is another common anti-seizure medication that must be avoided. Phenytoin is toxic to mitochondria and can severely worsen mitochondrial dysfunction [1]. Long-term use is also known to cause damage to the cerebellum (the part of the brain that controls balance), which can worsen the neurological symptoms already associated with MELAS [4][5].
- Lactated Ringer’s IV Solution: This is a common IV fluid given in emergency rooms or ambulances for hydration. However, it contains sodium lactate [2][6]. Because MELAS impairs your body’s ability to process oxygen properly, your body already produces too much lactic acid on its own [3]. Giving you more lactate through an IV overloads your system’s ability to clear it, which can drastically worsen lactic acidosis (a dangerous buildup of acid in your blood) [2][7].
Other Medications That Require Caution
While the three listed above are the most critical to avoid entirely, you must also be highly cautious with:
- Metformin: A common diabetes drug that carries a high risk of worsening lactic acidosis and is generally avoided in mitochondrial disease [8].
- Certain Anesthetics and Antibiotics: Some general anesthetics (like propofol) and certain antibiotics can exacerbate mitochondrial instability. Always ensure an anesthesiologist is aware of your MELAS diagnosis before any surgery [9].
Why These Treatments are Toxic in MELAS
Your cells rely on mitochondria to turn the food you eat and the oxygen you breathe into energy. In MELAS, a genetic mutation means your mitochondria are already struggling to produce enough energy [3].
When a drug like Valproic Acid or Phenytoin is introduced, it acts like a roadblock in an already failing power grid, completely shutting down energy production and causing liver or brain cells to become severely damaged [1].
Furthermore, because your cells cannot use oxygen efficiently, they rely on a backup energy system that produces lactate as a byproduct [3]. Your liver usually clears this lactate, but in MELAS, the liver is too overwhelmed [3][10]. Adding more lactate directly into your bloodstream via a Lactated Ringer’s IV pushes this fragile system over the edge, leading to a life-threatening acid buildup [2][3].
Protecting Yourself in an Emergency
Because emergency responders and emergency room doctors may not be familiar with the rare specific dangers of MELAS, you must be prepared to advocate for yourself when you are sick or injured:
- Carry a Medical Alert Card: Always wear a medical alert bracelet and carry an emergency alert card in your wallet [11][12]. The card should clearly state: “MELAS SYNDROME: DO NOT GIVE VALPROIC ACID, PHENYTOIN, OR LACTATED RINGER’S” [11][13]. This improves communication and reduces the time needed to inform clinical staff of your complex medical needs [14][15]. You should also add this information to your smartphone’s Medical ID or emergency lock screen.
- Have an Emergency Protocol Letter: Ask your specialist to write an “Emergency Information Form” or letter of intent [16][17]. Keep copies in your home, car, and bag. This letter should outline safe alternative seizure medications (such as Levetiracetam/Keppra, which is frequently used as a safer alternative in mitochondrial conditions [18]) and safe IV fluids (like normal saline with dextrose).
- Inform Your Inner Circle: Ensure your family, friends, and coworkers know about these specific drug dangers so they can speak up for you if you are unable to communicate during a stroke-like episode or seizure.
Common questions in this guide
Why is Valproic Acid dangerous for people with MELAS syndrome?
Can I receive Lactated Ringer's IV fluid if I have MELAS?
What anti-seizure medications should be avoided with MELAS syndrome?
How can I protect myself in a medical emergency with MELAS syndrome?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.What are the safest alternative medications you recommend to treat a seizure if I experience one?
- 2.Can you provide me with an official emergency protocol letter signed by you that I can hand to ER doctors?
- 3.What type of IV fluids should be explicitly listed as safe on my medical alert card?
- 4.Are there any other daily medications or antibiotics I should avoid based on my specific genetic mutation?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
Related questions
References
References (18)
- 1
Epilepsy in MELAS.
Finsterer J, Zarrouk-Mahjoub S
Pediatric neurology 2017; (67()):e7-e8 doi:10.1016/j.pediatrneurol.2016.10.015.
PMID: 27867040 - 2
Haemorrhagic Transformation of a MELAS Stroke-Like Lesion.
Bensaidane MR, Camden MC, Savard M
The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques 2020; (47(1)):117-118 doi:10.1017/cjn.2019.317.
PMID: 31648660 - 3
Molecular biomarkers correlate with brain grey and white matter changes in patients with mitochondrial m.3243A > G mutation.
Evangelisti S, Gramegna LL, La Morgia C, et al.
Molecular genetics and metabolism 2022; (135(1)):72-81 doi:10.1016/j.ymgme.2021.11.012.
PMID: 34916127 - 4
Phenytoin-related ataxia in patients with epilepsy: clinical and radiological characteristics.
Shanmugarajah PD, Hoggard N, Aeschlimann DP, et al.
Seizure 2018; (56()):26-30 doi:10.1016/j.seizure.2018.01.019.
PMID: 29427835 - 5
Irreversible Cerebellar Atrophy as a Complication of Short-Term Phenytoin Exposure: Clinical Improvement Following Discontinuation of the Culprit.
Algahtani H, Shirah B, Alqahtani AJ, Al-Malki AQ
Journal of epilepsy research 2020; (10(2)):96-99 doi:10.14581/jer.20016.
PMID: 33659203 - 6
Comments on "A Case of MELAS With the m.3243A>G Variant of the MT-TL1 Gene Mimicking Acute Intermittent Porphyria".
Finsterer J
Journal of clinical neurology (Seoul, Korea) 2022; (18(5)):597-598 doi:10.3988/jcn.2022.18.5.597.
PMID: 36062779 - 7
Metabolic remodeling in hiPSC-derived myofibers carrying the m.3243A>G mutation.
Valdebenito GE, Chacko AR, Chung CY, et al.
Stem cell reports 2025; (20(4)):102448 doi:10.1016/j.stemcr.2025.102448.
PMID: 40086445 - 8
Mitochondrial encephalopathy, lactic acidosis, and stroke-like episodes diagnosed after metformin-triggered stroke-like episodes.
Murakami K, Sakamoto K, Ishiguchi H, Ito H
Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association 2023; (32(5)):107080 doi:10.1016/j.jstrokecerebrovasdis.2023.107080.
PMID: 36933522 - 9
Surgical Complication Following Urgent Appendectomy and Considerations in Surgical Management of a Patient With Mitochondrial Encephalopathy, Lactic Acidosis, and Stroke-Like Episodes (MELAS).
Cassimatis N, Ruzicka F, Reilly K, Kumar R
Cureus 2023; (15(5)):e39129 doi:10.7759/cureus.39129.
PMID: 37332441 - 10
Varied Responses to a High m.3243A>G Mutation Load and Respiratory Chain Dysfunction in Patient-Derived Cardiomyocytes.
Ryytty S, Modi SR, Naumenko N, et al.
Cells 2022; (11(16)) doi:10.3390/cells11162593.
PMID: 36010669 - 11
Medical Alert Cards for patients with an anorectal malformation: a useful tool to increase awareness.
Bokova E, Elhalaby I, Prasade N, et al.
Pediatric surgery international 2024; (40(1)):301 doi:10.1007/s00383-024-05886-8.
PMID: 39522071 - 12
Medical Alert Cards for Pediatric Patients With Antegrade Continence Enemas to Enhance Awareness.
Bokova E, Prasade N, Elhalaby I, et al.
The Journal of surgical research 2024; (303()):206-214 doi:10.1016/j.jss.2024.09.020.
PMID: 39369593 - 13
Medical alert card: a valuable tool in the management of Hirschsprung's-associated enterocolitis from parental perspective.
Muntean A, Stoica I, Matcovici M, et al.
Pediatric surgery international 2020; (36(12)):1423-1428 doi:10.1007/s00383-020-04754-5.
PMID: 33034716 - 14
Evaluation of the Effectiveness of the Adverse Drug Reaction Alert Card System in Preventing the Recurrence of Adverse Drug Reactions.
Mulkalwar S, Chitale S, Dandage P, et al.
Cureus 2024; (16(7)):e64653 doi:10.7759/cureus.64653.
PMID: 39149672 - 15
'Just knowing it's there gives me comfort': Exploring the benefits and challenges of autism alert cards.
Edwards C, Love AM, Flower RL, et al.
Autism : the international journal of research and practice 2025; (29(3)):673-683 doi:10.1177/13623613241286025.
PMID: 39422173 - 16
An assessment of information needs and workflows for emergency service providers and caregivers of children with medical complexity.
Honcoop A, McCulloh RJ, Kerns E, et al.
BMC health services research 2023; (23(1)):453 doi:10.1186/s12913-023-09366-y.
PMID: 37158902 - 17
[Emergency card, emergency medication, and information leaflet for the prevention and treatment of adrenal crisis (Addison crisis): an Austrian consensus document].
Pilz S, Krebs M, Bonfig W, et al.
Journal fur klinische Endokrinologie und Stoffwechsel 2022; (15(1)):5-27 doi:10.1007/s41969-022-00155-2.
PMID: 35251520 - 18
Comparison of the efficacy and safety of levetiracetam and phenytoin in the treatment of established status epilepticus: A systematic review and meta-analysis.
Yang L, Dong XZ, Cui XH, et al.
Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia 2021; (89()):422-429 doi:10.1016/j.jocn.2021.05.004.
PMID: 34053822
This page provides information on contraindicated medications for MELAS syndrome for educational purposes only. Always consult your neurologist, geneticist, or metabolic specialist before changing medications or establishing emergency care protocols.
Get notified when new evidence is published on MELAS.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.